Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase 1/2 1

Status

Completed 4Terminated 3

Sponsor Class

INDUSTRY 6OTHER_GOV 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 7

Conditions

Breast Neoplasms 33Colorectal Neoplasms 13Neoplasms 11Pain, Postoperative 10Lung Neoplasms 9Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Melanoma 6Leukemia, Myeloid, Acute 5Ovarian Neoplasms 4Myoma 4Lymphoma, Non-Hodgkin 4Leiomyoma 4Hemorrhage 4Head and Neck Neoplasms 4Glioblastoma 4Colonic Neoplasms 4Agnosia 4Skin Neoplasms 3Recurrence 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neurotoxicity Syndromes 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Myelodysplastic Syndromes 3Multiple Endocrine Neoplasia Type 1 3

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Sodium Chloride × Clear all
NCT04863248 2023-04-14

PRESERVE 4

G1 Therapeutics, Inc.

Phase 2 Terminated
10 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02049151 2017-08-23

START2

EMD Serono

Phase 3 Terminated
35 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03117335 2017-04-17

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.

Phase 3 Completed
560 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00854308 2017-03-31

A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)

Genentech, Inc.

Phase 2 Completed
137 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01015443 2016-10-26

INSPIRE

Merck KGaA, Darmstadt, Germany

Phase 3 Terminated
285 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00960115 2015-10-21

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Merck KGaA, Darmstadt, Germany

Phase 1/2 Completed
178 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01836575 2013-04-22

PS2

Instituto Nacional de Cancer, Brazil

Phase 3 Completed
228 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡